N-Acetylcysteine May Reduce the Likelihood of Contrast-Induced Nephropathy in Patients Undergoing Percutaneous Coronary Intervention
Hurst's the Heart Online Update: N-Acetylcysteine May Reduce the Likelihood of Contrast-Induced Nephropathy in Patients Undergoing Percutaneous Coronary Intervention
N-Acetylcysteine May Reduce the Likelihood of Contrast-Induced Nephropathy in Patients Undergoing Percutaneous Coronary Intervention
Hurst's the Heart Online Update: N-Acetylcysteine May Reduce the Likelihood of Contrast-Induced Nephropathy in Patients Undergoing Percutaneous Coronary Intervention